Ana Karina Aranda-Rivera

22PUBLICATIONS
29CO-AUTHORS
Neurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Free radical chemistryMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Apr 14, 2025
Effect of N-Acetylcysteine in Mitochondrial Function, Redox Signaling, and Sirtuin 3 Levels in the Heart During Cardiorenal Syndrome Type 4 Development.

Isabel Amador-Martínez, Omar Emiliano Aparicio-Trejo, Ana Karina Aranda-Rivera

|Apr 14, 2025
Sulforaphane Restores Mitochondrial β-Oxidation and Reduces Renal Lipid Accumulation in a Model of Releasing Unilateral Ureteral Obstruction.

Ana Karina Aranda-Rivera, Isabel Amador-Martínez, Omar Emiliano Aparicio-Trejo

|Nov 14, 2023
Mitochondrial Impairment: A Link for Inflammatory Responses Activation in the Cardiorenal Syndrome Type 4.

Isabel Amador-Martínez, Omar Emiliano Aparicio-Trejo, Bismarck Bernabe-Yepes

|Aug 26, 2023
Quercetin and Ferroptosis.

Alfredo Cruz-Gregorio, Ana Karina Aranda-Rivera

|Apr 04, 2023
α-Mangostin induces oxidative damage, mitochondrial dysfunction, and apoptosis in a triple-negative breast cancer model.

Alfredo Cruz-Gregorio, Ana Karina Aranda-Rivera, Omar Emiliano Aparicio-Trejo

|Mar 29, 2023
Targeting Mitochondrial Therapy in the Regulation of HPV Infection and HPV-Related Cancers.

Alfredo Cruz-Gregorio, Ana Karina Aranda-Rivera, Giovanni N Roviello

Pageof 4